Professor Andrew Quest and his team at the University of Chile have spent the last 25 years investigating the role of a protein called caveolin-1 (CAV1). CAV1 appears to have the unusual ability to act as both a tumour suppressor and an oncogene. The researchers have significantly improved our understanding of the role that CAV1 plays in different forms of cancers such as melanoma, breast, and colon cancer – rethinking conventional wisdom on cancer development in the process.
Read the full article and more on Research Features – Health & Medicine
Read/Download pdf on Research Features – Andrew-Quest
The whole digital publication of the issue containing this article is on Research Features Magazine- ISSUE 146